SCHEMBL545592

SCHEMBL545592

CCC(CC)c1cc(C)nc2c(-c3sc(-c4cccc(C)n4)cc3C)c(C)nn12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 3/20 0.37
MAPT P10636 3/20 0.37
CRHR1 P34998 8/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALOX15 P16050 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
PI4KB Q9UBF8 1/20 0.34
ATM Q13315 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL545543 0.80 HPGD (0.40) HPGDPOLBKDM4EMAPTCRHR1
Hydrochloric Acid SCHEMBL545948 0.78 CRHR1 (0.40) HPGDPOLBCRHR1
SCHEMBL544990 0.76 HPGD (0.40) HPGDPOLBKDM4EMAPTCRHR1
SCHEMBL544939 0.76 CRHR1 (0.40) HPGDPOLBKDM4EMAPTCRHR1
SCHEMBL2931270 0.75 HPGD (0.39) HPGDPOLBKDM4EMAPTCRHR1
SCHEMBL544898 0.75 MAPT (0.42) HPGDPOLBKDM4EMAPTCRHR1
SCHEMBL2497805 0.74 HPGD (0.38) HPGDPOLBKDM4EMAPTCRHR1
SCHEMBL12409295 0.74 CRHR1 (0.40) HPGDPOLBKDM4EMAPTCRHR1
SCHEMBL3921459 0.74 CRHR1 (0.55) CRHR1
SCHEMBL2178265 0.73 CRHR1 (0.39) HPGDPOLBKDM4EMAPTCRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110580-B2 Thiophene pyrazolopyrimidine compounds ELI LILLY AND COMPANY (US) 2012-02-07 US disclosed
US-8110580-B2 Thiophene pyrazolopyrimidine compounds ELI LILLY AND COMPANY (US) 2012-02-07 US disclosed
US-8110580-B2 Thiophene pyrazolopyrimidine compounds ELI LILLY AND COMPANY (US) 2012-02-07 US disclosed
US-20100022560-A1 THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS CHEN ZHAOGEN 2010-01-28 US disclosed
US-20100022560-A1 THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS CHEN ZHAOGEN 2010-01-28 US disclosed
WO-2008036541-A1 THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS ELI LILLY AND COMPANY (US) 2008-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022560-A1 THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS CRH, CRHR1, CRHR2 HPGD 1818/4885POLB 4655/4885KDM4E 4111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.